| Publication Number | Title | Priority Date |
|---|---|---|
| CN-114149722-A | Hydrophilic oleophobic material, preparation method and application thereof | 2021-12-29 |
| CN-113842676-A | Super-hydrophilic-super-oleophobic particle for oily sewage treatment and preparation method and application thereof | 2021-10-20 |
| CN-113848190-A | Rapid detection method and detection device for medium-long chain perfluorocarboxylic acid in water sample | 2021-09-26 |
| CN-113791057-A | Perfluoro compound high-throughput screening method based on fluorescent sensor array | 2021-09-15 |
| CN-215840207-U | PFNA operation arm fixing device | 2021-08-31 |
| CN-113817138-A | UV-cured fingerprint-resistant resin with high fluorine content and preparation method and application thereof | 2021-08-30 |
| AU-2021107450-A4 | Passive contaminated surface water treatment system | 2021-08-24 |
| DE-202021104684-U1 | Remediation of soils and / or water with activated peroxydisulphate / monoperoxysulphate | 2021-08-23 |
| CN-113419013-A | Method for analyzing perfluoroalkyl acid pollutants in environmental water sample and application | 2021-08-11 |
| CN-113671068-A | Method for analyzing environmental pollutant targeting exposure component in blood plasma and application thereof | 2021-07-27 |
| PMID | Publication Date | Title | Journal |
|---|---|---|---|
| 36638633 | 2023-03-01 | Per- and polyfluoroalkyl substances (PFAS) inhibit cytochrome P450 CYP3A7 through direct coordination to the heme iron and water displacement | Journal of inorganic biochemistry |
| 36270329 | 2022-12-01 | Exposure to a mixture of per-and polyfluoroalkyl substances modulates pulmonary expression of ACE2 and circulating hormones and cytokines | Toxicology and applied pharmacology |
| 36122607 | 2022-10-01 | Structure-activity relationship analysis of perfluoroalkyl carbonic acids on human and rat placental 3β-hydroxysteroid dehydrogenase activity | Toxicology |
| 35752307 | 2022-08-15 | In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays | Toxicology and applied pharmacology |
| 35337807 | 2022-05-01 | Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes | Toxicology and applied pharmacology |
| 35266797 | 2022-03-01 | Gestational Perfluoroalkyl Substance Exposure and DNA Methylation at Birth and 12 Years of Age: A Longitudinal Epigenome-Wide Association Study | Environmental health perspectives |
| 34450368 | 2022-01-01 | Critical new insights into the binding of poly- and perfluoroalkyl substances (PFAS) to albumin protein | Chemosphere |
| 34500360 | 2021-12-01 | Exposure to per- and polyfluoroalkyl substances associates with an altered lipid composition of breast milk | Environment international |
| 34371090 | 2021-10-01 | Effects of an environmentally relevant PFAS mixture on dopamine and steroid hormone levels in exposed mice | Toxicology and applied pharmacology |
| 34585601 | 2021-09-01 | Associations of Maternal Serum Perfluoroalkyl Substances Concentrations with Early Adolescent Bone Mineral Content and Density: The Health Outcomes and Measures of the Environment (HOME) Study | Environmental health perspectives |
